¸²ÇÁÀý ÀüÀÌ°¡ ¾ø´Â °áÁ÷Àå¾Ï¿¡¼ p27kip1ÀÇ ¿¹ÈÄÀÎÀڷμÀÇ ¿ªÇÒ
Prognostic Significance of p27kip1 Expression in Node Negative Colorectal Carcinoma
¼Û»óÇö, ¹èº´³ë, ÀÌ¿ì¿ë, ¾ç±ÙÈ£, ±è±âȯ, ÇѼ¼È¯, ±èÈ«ÁÖ, ±è¿µ´ö, ±èÈ«¿ë, ±èÁ¤¿¬,
¼Ò¼Ó »ó¼¼Á¤º¸
¼Û»óÇö ( Song Sang-Hyun )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
¹èº´³ë ( Bae Byung-Noe )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
ÀÌ¿ì¿ë ( Lee Woo-Yong )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
¾ç±ÙÈ£ ( Yang Keun-Ho )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
±è±âȯ ( Kim Ki-Hwan )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
ÇѼ¼È¯ ( Han Se-Hwan )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
±èÈ«ÁÖ ( Kim Hong-Ju )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
±è¿µ´ö ( Kim Young-Duk )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
±èÈ«¿ë ( Kim Hong-Yong )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¿Ü°úÇб³½Ç
±èÁ¤¿¬ ( Kim Jung-Yeon )
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø º´¸®Çб³½Ç
KMID : 0356720070230010034
Abstract
Purpose: Dukes¡¯ A & B colorectal cancer patients are often excluded from adjuvant chemotherapy following potentially curative surgery because they are expected to have good long-term survival. However, actually 20¡30% of these patients suffer from recurrent disease, so it would be helpful for these patients of recurrent disease to be able to select a high risk group.
Methods: In 78 Dukes¡¯ A & B colorectal cancers, we investigated by immunohistochemistry the role of molecular markers, such as p27kip1, p53, Ki-67, and Skp2, in identifying high-risk patients.
Results: Patients with low p27kip1 expression showed poor overall survival compared to those with high p27kip1 expressions (55.3 versus 66.7 months, P=0.018). The only significant factor associated with p27kip1 expression was p53 expression. The low p27kip1 expression and positive p53 expression group had poor overall survival (54.3 months, P=0.036).
Conclusion: In a node-negative colorectal carcinoma, the molecular marker p27kip1 does not play an independent prognostic role, but it may have prognostic significance in correlation with other markers such as p53, Ki-67, and Skp2. The assessment of molecular alterations may be useful to node-negative colorectal patients in identifying the high risk group that may benefit from adjuvant chemotherapy. J Korean Soc Coloproctol 2007;23:34-40
Å°¿öµå
°áÁ÷Àå¾Ï;p27kip1;Skp2;¿¹ÈÄ
Colorectal cancer;p27kip1;Skp2;Prognosis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸